Gleason drift in the NIHR ProtecT study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gleason drift in the NIHR ProtecT study

Published:2015-01-07 Issue:3 Volume:66 Page:438-446
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Oxley Jon¹,Simpkin Andrew²,Goepel John³,Varma Murali⁴,Griffiths David⁴,Grigor Ken⁵,Mayer Nick⁶,Warren Anne⁷,Deshmukh Nayneeta⁸,Bhattarai Selina⁹,Dormer John⁶,Hounsome Luke¹⁰,Adamczyk Lukasz A¹,Metcalfe Christopher²,Lane J Athene²,Davis Michael²,Donovan Jenny L²,Neal David E¹¹,Hamdy Freddy C¹²,Robinson Mary C¹³,

Affiliation:

1. Department of Cellular Pathology; Southmead Hospital; Bristol UK

2. School of Social and Community Medicine; University of Bristol; Bristol UK

3. Department of Pathology; Royal Hallamshire Hospital; Sheffield UK

4. Department of Pathology; University Hospital of Wales; Cardiff UK

5. Department of Pathology; Western General Hospital; Edinburgh UK

6. Department of Pathology; University of Leicester; Leicester UK

7. Department of Pathology; University of Cambridge; Cambridge UK

8. CRUK Institute of Cancer Studies; University of Birmingham; Birmingham UK

9. Department of Pathology; Leeds Teaching Hospitals NHS Trust; Leeds UK

10. Knowledge and Intelligence Team (South West); Public Health England; Bristol UK

11. Department of Oncology; University of Cambridge; Cambridge UK

12. Nuffield Department of Surgery; University of Oxford; Oxford UK

13. Department of Cellular Pathology; Royal Victoria Infirmary; Newcastle UK

Funder

National Institute for Health Research

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.12549/fullpdf

Reference32 articles.

1. Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies;Lane;Eur. J. Cancer,2010

2. Implications of the International Society of Urological Pathology modified Gleason grading system;Egevad;Arch. Pathol. Lab. Med.,2012

3. Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?;Stark;J. Clin. Oncol.,2009

4. Prostate cancer and the Will Rogers phenomenon;Albertsen;J. Natl Cancer Inst.,2005

5. Gleason grading: past, present and future;Delahunt;Histopathology,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Risk Localized Prostate Cancer;Urologic Oncology;2022

2. Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT;Health Technology Assessment;2020-08

3. The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression;BJU International;2020-02-12

4. The percentage of high‐grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death;Histopathology;2019-08-13

5. Histopathologic False-positive Diagnoses of Prostate Cancer in the Age of Immunohistochemistry;American Journal of Surgical Pathology;2019-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3